Entity Common Stock, Shares Outstanding of Propanc Biopharma, Inc. from 29 Feb 2012 to 16 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Propanc Biopharma, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 29 Feb 2012 to 16 Feb 2026.
  • Propanc Biopharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 16 Feb 2026 was 15,859,280, a 37% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Propanc Biopharma, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 15,859,280 +4,247,498 +37% 16 Feb 2026 10-Q 17 Feb 2026 2026 Q2
Q3 2025 12,806,747 -675,215,270 -98% 24 Sep 2025 10-K 29 Sep 2025 2025 FY
Q1 2025 11,611,782 -40,533,166 -78% 15 May 2025 10-Q 15 May 2025 2025 Q3
Q4 2024 15,372* 12 Feb 2025 10-Q 14 Feb 2025 2025 Q2
Q3 2024 688,022,017 +673,188,807 +4538% 25 Sep 2024 10-K 30 Sep 2024 2024 FY
Q1 2024 52,144,948 -3,236,259,774 -98% 20 Feb 2024 10-Q 20 Feb 2024 2024 Q2
Q3 2023 14,833,210 -662,344,507 -98% 27 Sep 2023 10-K 28 Sep 2023 2023 FY
Q1 2023 3,288,404,722 12 May 2023 10-Q 15 May 2023 2023 Q3
Q4 2022 1,763,908,545 +1,702,491,018 +2772% 09 Feb 2023 10-Q 10 Feb 2023 2023 Q2
Q3 2022 677,177,717 +636,078,930 +1548% 26 Sep 2022 10-K 28 Sep 2022 2022 FY
Q2 2022 122,193,541 16 May 2022 10-Q 16 May 2022 2022 Q3
Q4 2021 61,417,527 +57,782,237 +1589% 14 Feb 2022 10-Q 14 Feb 2022 2022 Q2
Q3 2021 41,098,787 -647,571,831 -94% 24 Sep 2021 10-K 28 Sep 2021 2021 FY
Q1 2021 5,967,110 -41,119,332 -87% 14 May 2021 10-Q 14 May 2021 2021 Q3
Q4 2020 3,635,290 -1,554,080 -30% 09 Feb 2021 10-Q 12 Feb 2021 2021 Q2
Q3 2020 688,670,618 +687,500,592 +58759% 28 Sep 2020 10-K 01 Oct 2020 2020 FY
Q1 2020 47,086,442 -373,713,606 -89% 11 May 2020 10-Q 15 May 2020 2020 Q3
Q4 2019 5,189,370 -328,707,207 -98% 13 Feb 2020 10-Q 14 Feb 2020 2020 Q2
Q3 2019 1,170,026 -160,869,028 -99% 02 Oct 2019 10-K 15 Oct 2019 2019 FY
Q1 2019 420,800,048 +382,475,857 +998% 10 May 2019 10-Q 15 May 2019 2019 Q3
Q4 2018 333,896,577 +312,715,990 +1476% 14 Feb 2019 10-Q 14 Feb 2019 2019 Q2
Q3 2018 162,039,054 +155,549,039 +2397% 17 Sep 2018 10-K 17 Sep 2018 2018 FY
Q1 2018 38,324,191 +34,572,315 +921% 10 May 2018 10-Q 10 May 2018 2018 Q3
Q4 2017 21,180,587 -893,301,543 -98% 08 Feb 2018 10-Q 09 Feb 2018 2018 Q2
Q3 2017 6,490,015 -783,190,977 -99% 28 Sep 2017 10-K 28 Sep 2017 2017 FY
Q1 2017 3,751,876 -718,177,644 -99% 08 May 2017 10-Q 08 May 2017 2017 Q3
Q4 2016 914,482,130 +438,871,880 +92% 14 Feb 2017 10-Q 14 Feb 2017 2017 Q2
Q3 2016 789,680,992 +433,056,395 +121% 26 Sep 2016 10-K 28 Sep 2016 2016 FY
Q1 2016 721,929,520 +530,241,115 +277% 11 May 2016 10-Q 16 May 2016 2016 Q3
Q4 2015 475,610,250 +384,655,150 +423% 09 Feb 2016 10-Q 16 Feb 2016 2016 Q2
Q3 2015 356,624,597 +274,180,497 +333% 30 Sep 2015 10-K 30 Sep 2015 2015 FY
Q1 2015 191,688,405 16 Feb 2015 10-Q 17 Feb 2015 2015 Q2
Q4 2014 90,955,100 +18,270,332 +25% 19 Nov 2014 10-Q 19 Nov 2014 2015 Q1
Q3 2014 82,444,100 +10,964,333 +15% 14 Oct 2014 10-K 14 Oct 2014 2014 FY
Q2 2014 72,684,768 +2,052,500 +2.9% 19 May 2014 10-Q 20 May 2014 2014 Q3
Q4 2013 72,684,768 -1,007,031 -1.4% 10 Feb 2014 10-Q 14 Feb 2014 2014 Q2
Q3 2013 71,479,767 -1,525,830 -2.1% 11 Oct 2013 10-K 15 Oct 2013 2013 FY
Q2 2013 70,632,268 -2,148,612 -3% 20 May 2013 10-Q 20 May 2013 2013 Q3
Q1 2013 72,987,839 +984,563 +1.4% 19 Feb 2013 10-Q 20 Feb 2013 2013 Q2
Q4 2012 73,691,799 19 Nov 2012 10-Q 19 Nov 2012 2013 Q1
Q3 2012 73,005,597 11 Oct 2012 10-K 15 Oct 2012 2012 FY
Q2 2012 72,780,880 18 May 2012 10-Q 21 May 2012 2012 Q3
Q1 2012 72,003,276 29 Feb 2012 10-Q/A 07 Mar 2012 2012 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.